Kevin Sharer
Kevin Sharer
Kevin W. Shareris an American businessman, and former Chairman of the Board and Chief Executive Officer of the American biotechnology company Amgen Inc. He serves on the corporate board of Northrop-Grumman...
ProfessionBusiness Executive
Date of Birth2 March 1948
annual billion compound confident growth guidance low period rate remain sales
We remain confident in our long-term guidance of compound annual growth rate for sales and EPS of low 20s for the 2001-2005 period and sales between $8 billion and $9 billion in 2005,
cancer class community continuing cycling delighted donation forward looks million pleased resulted success support tour wellness
We are delighted with the inaugural Amgen Tour of California. We are also pleased with the success of our Breakaway from Cancer initiative, which resulted in a donation of $1.1 million to The Wellness Community to support cancer patients. Amgen looks forward to our continuing sponsorship of this world class cycling event.
balancing continued delivering earnings ensure investment products success time
We are balancing the need for continued investment to ensure the success of these new products while at the same time delivering continued earnings growth.
full patient protect safety tests
We need to have full tests to protect patient safety.
I think Amgen will be a multi-therapeutic company.
almost lose market overnight
It's not like pills, where almost overnight you can lose 98% market share. That's not going to happen, because these are much more complicated drugs to manufacture.
effect hard predict
It'll have an effect on Amgen, for sure, but it's just hard to predict what.
across additional benefits cancer charity city community component empower funds help host join members patients people proud raise ride tour
Breakaway from Cancer is an integral, complementary component of the Amgen Tour of California, and it benefits cancer patients across the country. Amgen was proud to host the Breakaway from Cancer charity ride in our headquarters city and join members of the community to raise additional funds to help empower people with cancer so they can live well with the disease.
complexity executive global growing integrate marketing multiple plan product require research sales scale worldwide
Amgen is growing rapidly, and our scale and complexity require that we have one executive be responsible for research and development, ... In addition, we plan multiple global product launches, and we need one executive to integrate our worldwide sales and marketing activities.